Inactive Instrument

News Panacos Pharmaceuticals, Inc. Other OTC

Equities

PANC

US69811Q1067

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference	07-08-31	BU
Panacos Pharma : Panacos Reports Second Quarter 2007 Financial Results	07-07-31	BU
Panacos Pharma : Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference	07-07-25	BU
Panacos Pharma : Panacos to Report Second Quarter Results for 2007	07-07-24	BU
Panacos Pharma : Panacos Secures $20 Million Debt Financing	07-06-28	BU
Panacos Pharma : Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study	07-06-20	BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	07-06-06	BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	07-06-06	BU
Panacos Pharma : Panacos to Present at Bear Stearns Biotech Confab	07-05-31	BU
Panacos Pharma : Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat	07-05-29	BU
Panacos Pharma : Panacos to Present at Bank of America Health Care Conference	07-05-23	BU
Panacos Pharma : Panacos Reports First Quarter 2007 Financial Results	07-05-02	BU
Panacos Pharma : Panacos to Present at Deutsche Bank Health Care Conference	07-04-26	BU
Panacos Pharma : Panacos to Report First Quarter Results for 2007	07-04-25	BU
Panacos Pharma : Panacos Announces New Board Member	07-04-16	BU
Panacos Pharma : Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference	07-04-04	BU
Panacos Pharma : Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy	07-03-12	BU
Panacos Pharma : Panacos to Present at Citigroup Small & Mid-Cap Conference	07-03-08	BU
Panacos Pharma : Panacos to Present at Cowen Health Care Conference	07-03-06	BU
Panacos Pharma : Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040	07-02-27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Panacos Pharmaceuticals, Inc. Other OTC

Equities

PANC

US69811Q1067

Summary

Filters